June 2020
Volume 61, Issue 7
Free
ARVO Annual Meeting Abstract  |   June 2020
NMN supplementation prevents vascular senescence in experimental diabetic retinopathy
Author Affiliations & Notes
  • Manuela Bartoli
    Ophthalmology, Augusta University, Augusta, Georgia, United States
  • Menaka Thounaojam
    Ophthalmology, Augusta University, Augusta, Georgia, United States
  • Hossameldin Abouhish
    Ophthalmology, Augusta University, Augusta, Georgia, United States
  • Diana Gutsaeva
    Ophthalmology, Augusta University, Augusta, Georgia, United States
  • Folami Lamoke Powell
    Biochemistry and Molecular Biology, Augusta University, Augusta, Georgia, United States
  • Ravirajsinh Jadeja
    Biochemistry and Molecular Biology, Augusta University, Augusta, Georgia, United States
  • Pamela M Martin
    Biochemistry and Molecular Biology, Augusta University, Augusta, Georgia, United States
  • Footnotes
    Commercial Relationships   Manuela Bartoli, None; Menaka Thounaojam, None; Hossameldin Abouhish, None; Diana Gutsaeva, None; Folami Powell, None; Ravirajsinh Jadeja, None; Pamela Martin, None
  • Footnotes
    Support  EY028714
Investigative Ophthalmology & Visual Science June 2020, Vol.61, 1168. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Manuela Bartoli, Menaka Thounaojam, Hossameldin Abouhish, Diana Gutsaeva, Folami Lamoke Powell, Ravirajsinh Jadeja, Pamela M Martin; NMN supplementation prevents vascular senescence in experimental diabetic retinopathy. Invest. Ophthalmol. Vis. Sci. 2020;61(7):1168.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose : Microvascular dysfunction contributes to diabetic retinopathy (DR). Our previous studies have shown that hyperglycemia promotes retinal vascular stress-induced premature senescence (SIPS). This effect is associated with loss of nicotinamide phosphoribosyltransferase (NAMPT), the rate-limiting enzyme in the nicotinamide adenine dinucleotide (NAD+) salvage pathway, converting nicotinamide to nicotinamide mononucleotide (NMN) and enabling NAD+ biosynthesis. Here we have investigated whether exogenous supplementation of NMN could override the effects of hyperglycemia in lowering NAD+ levels and could prevent retinal vascular senescence in a rat model of type I diabetes.

Methods : Rats were made diabetic by intravenous injection of streptozotocin (60mg/Kg). Two weeks after the onset of hyperglycemia (250mg/dl or more) half of the diabetic rats was fed with NMN (100mg/Kg, daily). Six weeks after the starting of the treatment, rats were sacrificed and processed for different molecular and morphological analyses. Hematoxylin/eosin staining was used for histopathological evaluation and morphometric analysis of retinal sections. Immunohistochemistry was used to assess reactive oxygen species formation (DHE). Western blotting was used to measure NAMPT levels and of senescence and oxidative stress markers and to assess albumin vascular extravasation. NAD+ was measured with a colorimentric assay.

Results : In diabetic rats we found signficant decreased levels of NAMPT and NAD+. Treatments with NMN prevented NAD+ loss without rescuing NAMPT expression. Furthermore, NMN significantly decreased diabetes-induced up-regulation of reactive oxygen species and levels of the oxidative stress markers 4-HNE and nitrotyrosine. Furthermore, we found that NMN supplementation in diabetic rats halted the expression of senescence markers evoking the occurrence of SIPS. These normalizing effects of NMN on the retinal vasculature, were further confirmed by the results of this treatment in preventing diabetes –induced albumin extravasation, as sign of vascular hyperpermeability, in diabetic rats.

Conclusions : Our studies suggest that alterations of the NAMPT-NAD+ axis affects the retinal vasculature in diabetes and support the use of NMN supplementation in preserving retinal vascular function in DR.

This is a 2020 ARVO Annual Meeting abstract.

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×